Integrin αvβ3-targeted radionuclide therapy with 177Lu-AB-3PRGD2 in multiple advanced metastatic solid tumors: A prospective, single-arm, single-center, investigator-initiated clinical trial.

177Lu-AB-3PRGD2 - Peking Union Medical College

https://www.asco.org/abstracts-presentations/261759

Hao Fu; Jingxiong Huang; Wei Guo; Liang Zhao; Hua Wu; Fan Wang; Haojun Chen

Apr 21, 2026